Nihon Kohden has expanded its portfolio of neurology electrode devices by acquiring a 71.4% stake in NeuroAdvanced Corp., the parent company of Ad-Tech Medical Instrument Corporation.
The Japanese company noted that acquisition “Nihon Kohden’s established expertise in electro encephalograph (EEG) systems with Ad-Tech’s specialized electrodes, strengthening the company’s ability to support comprehensive epilepsy care.”
Go deeper with GlobalData
Archimed, an investment firm and previous owner of Ad-Tech, has the remaining stake in Ad-Tech and will act as a minority joint venture partner with Nihon Kohden. The acquisition is estimated to cost approximately ¥16bn ($103.66m).
GlobalData estimates that the global neurology device market is expected to expand from being worth approximately $13.1bn in 2024 to over $20.8bn by 2033. The neurological diagnostic and monitoring equipment device segment is expected to grow from $1.5bn to over $1.7bn over the same period.
Nihon Kohden noted that the acquisition is part of the company’s long-term BEACON 2030 vision. As part of FY2023 H1 financial statement, the company stated that as part of Phase II of BEACON 2030 vision it plans to make research and development (R&D) investments in patient monitors, ventilators, and Digital Health Solutions. The R&D investments total approximately ¥23.5bn ($152m).
“This acquisition represents a pivotal step in advancing critical solutions for epilepsy care,” said Roy Sakai, President of Nihon Kohden America. “By uniting our strengths, we’re enhancing our ability to provide end-to-end support for epilepsy—from accurate diagnosis to advanced interventions.”
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataAdding that this collaboration helps support these solutions for patients in acute neurocritical care situations, preserving function and enabling precision with intraoperative neuromonitoring (IONM) and enhancing usefulness of patient data using its analytics and digital health solutions (DHS).
Nihon Kohden’s portfolio consists of diagnostics systems such as EEG, electrocardiograph (ECG), automated haematology analysers, patient monitors, and treatment equipment including defibrillator, and pacemakers.
